Zheng Hua-Jie, Li Jun, Tang Ling-Feng, Guo Mei, Wei Ya-Nan, Cheng Wei
Department of Cardiac Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), No.30, Gaotanyan Road, Shapingba District, Chongqing, 400038, China.
Department of Prevention and Healthcare, Southwest Hospital, Third Military Medical University (Army Medical University), No.30, Gaotanyan Road, Shapingba District, Chongqing, 400038, China.
BMC Cardiovasc Disord. 2025 Apr 23;25(1):306. doi: 10.1186/s12872-025-04763-z.
New-onset postoperative atrial fibrillation (POAF) is common after transcatheter aortic valve replacement (TAVR). At present, the impact of POAF on cardiac remodeling after TAVR has not been thoroughly studied.
To investigate the impact of POAF on cardiac remodeling and its association with clinical outcomes after TAVR.
601 patients undergoing TAVR for severe aortic stenosis were evaluated. Of these, 253 patients were identified to have POAF, which was categorized as normal left ventricular mass index (LVMI) in 54 (21%) and high LVMI in 199 (79%). The primary endpoint was a composite of all-cause death, heart failure rehospitalization and disabling stroke. Reverse remodeling was assessed by transthoracic echocardiography.
In POAF patients, the 3-year cumulative incidence of primary composite outcome in the high LVMI subgroup was significantly higher than that in the normal LVMI subgroup (9.3 ± 3.3% vs. 13.5 ± 3.9%; p = 0.02). The incidence of LVMI regression after TAVR was lower in patients with POAF than in those without (65.6 ± 3.0% vs. 82.6 ± 2.7% at 3 years; p = 0.029). Furthermore, the 3-year cumulative incidence of the primary composite outcome and cardiovascular death was highest in the group of POAF without LVMI regression. Baseline LVMI (β = -1.73, p < 0.001) and POAF (β = -1.46, p < 0.001) were independent predictors of change in LVMI at one year.
Patients with POAF had less LVMI regression and impaired cardiac reverse remodeling after TAVR, which increased the incidence of all-cause death and heart failure rehospitalization. Therefore, clinicians should be more proactive in monitoring and treating POAF after TAVR.
经导管主动脉瓣置换术(TAVR)后新发术后房颤(POAF)很常见。目前,POAF对TAVR后心脏重塑的影响尚未得到充分研究。
探讨POAF对TAVR后心脏重塑的影响及其与临床结局的关系。
对601例因严重主动脉瓣狭窄接受TAVR的患者进行评估。其中,253例患者被确定患有POAF,其中54例(21%)左心室质量指数(LVMI)正常,199例(79%)LVMI升高。主要终点是全因死亡、心力衰竭再住院和致残性卒中的复合终点。通过经胸超声心动图评估逆向重塑。
在POAF患者中,高LVMI亚组的3年主要复合结局累积发生率显著高于正常LVMI亚组(9.3±3.3%对13.5±3.9%;p=0.02)。POAF患者TAVR后LVMI下降的发生率低于无POAF患者(3年时分别为65.6±3.0%对82.6±2.7%;p=0.029)。此外,在无LVMI下降的POAF组中,3年主要复合结局和心血管死亡的累积发生率最高。基线LVMI(β=-1.73,p<0.001)和POAF(β=-1.46,p<0.001)是1年时LVMI变化的独立预测因素。
POAF患者TAVR后LVMI下降较少且心脏逆向重塑受损,这增加了全因死亡和心力衰竭再住院的发生率。因此,临床医生在TAVR后应更积极地监测和治疗POAF。